{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:05:56Z","timestamp":1762459556938,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00198-018-4402-3","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T08:02:14Z","timestamp":1519804934000},"page":"1203-1209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Electron microscopic evaluation of bone from a patient treated with cinacalcet hydrochloride, maxacalcitol, and alfacalcidol for hyperparathyroid bone disease with secondary hyperparathyroidism"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3157-8051","authenticated-orcid":false,"given":"A.","family":"Yajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. F.","family":"Bonewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"issue":"3","key":"4402_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0272-6386(00)70198-3","volume":"35","author":"Y Tsukamoto","year":"2000","unstructured":"Tsukamoto Y, Hanaoka M, Matsuo T, Saruta T, Nomura M, Takahashi Y (2000) Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism. Am J Kidney Dis 35(3):458\u2013464","journal-title":"Am J Kidney Dis"},{"key":"4402_CR2","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM, Parfrey PS, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Dehmel B, Goodman WG, Dr\u00fceke T (2015) Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial. J Am Soc Nephrol 26:1466\u20131475","journal-title":"J Am Soc Nephrol"},{"key":"4402_CR3","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1002\/jbmr.126","volume":"25","author":"A Yajima","year":"2010","unstructured":"Yajima A, Inaba M, Tominaga Y, Nishizawa Y, Ikeda K, Ito A (2010) Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism. J Bone Miner Res 25:2374\u20132381","journal-title":"J Bone Miner Res"},{"key":"4402_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","volume":"67","author":"SM Moe","year":"2005","unstructured":"Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA, Dr\u00fceke TB, Cunningham J, Sherrard DJ, McCary LC, Olson KA, Turner SA, Martin KJ (2005) Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67:760\u2013771","journal-title":"Kidney Int"},{"unstructured":"Chertow GM, Blumenthal S, Turner S, Roppolo M, Stern L, Chi EM, Reed J; CONTROL Investigators (2006) Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. Clin J Am Soc Nephrol 1(2):305\u2013312","key":"4402_CR5"},{"key":"4402_CR6","doi-asserted-by":"publisher","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","volume":"10","author":"SC Palmer","year":"2013","unstructured":"Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GF (2013) Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLos Med 10:e1001436, review","journal-title":"PLos Med"},{"key":"4402_CR7","doi-asserted-by":"publisher","first-page":"30337","DOI":"10.1074\/jbc.M201804200","volume":"277","author":"L Canaff","year":"2002","unstructured":"Canaff L, Hendy GN (2002) Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 277:30337\u201330350","journal-title":"J Biol Chem"},{"key":"4402_CR8","doi-asserted-by":"publisher","first-page":"F1390","DOI":"10.1152\/ajprenal.00262.2006","volume":"292","author":"ME Rodriguez","year":"2007","unstructured":"Rodriguez ME, Almaden Y, Ca\u00f1adillas S, Canalejo A, Siendones E, Lopez I, Aguilera-Tejero E, Martin D, Rodriguez M (2007) The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands. Am J Physiol Renal Physiol 292:F1390\u2013F1395","journal-title":"Am J Physiol Renal Physiol"},{"doi-asserted-by":"crossref","unstructured":"Malluche HH, Mawad H, Monier-Faugere MC (2008) Effects of treatment of renal osteodystrophy on bone histology. Clin J Am Soc Nephrol 3 (Suppl 3):S157-S163, review","key":"4402_CR9","DOI":"10.2215\/CJN.02500607"},{"issue":"Pt A","key":"4402_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jsbmb.2014.01.002","volume":"144","author":"NN Lam","year":"2014","unstructured":"Lam NN, Triliana R, Sawyer RK, Atkins GJ, Morris HA, O\u2019Loughlin PD, Anderson PH (2014) Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency. J Steroid Biochem Mol Biol 144(Pt A):128\u2013131 Review","journal-title":"J Steroid Biochem Mol Biol"},{"doi-asserted-by":"crossref","unstructured":"Mizobuchi M, Ogata H, Koiwa F, Kinugasa E, Akizawa T (2009) Vitamin D and vascular calcification in chronic kidney disease. Bone 45 (Suppl 1):S26-29 Review","key":"4402_CR11","DOI":"10.1016\/j.bone.2009.01.011"},{"key":"4402_CR12","first-page":"834A","volume":"21","author":"A Yajima","year":"2010","unstructured":"Yajima A, Inaba M, Otsubo S, Nitta K, Akizawa T (2010) Cinacalcet hydrochloride with very low doses of vitamin D does not reduce the poorly mineralized bone areas in patients with secondary hyperparathyroidism. J Am Soc Nephrol 21:834A","journal-title":"J Am Soc Nephrol"},{"key":"4402_CR13","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534\u20132540","journal-title":"J Clin Invest"},{"unstructured":"Kidney disease: improving global outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Kidney Int (Suppl 113):S1\u2013130","key":"4402_CR14"},{"issue":"4 Suppl 3","key":"4402_CR15","first-page":"S1","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation (2003) K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1\u2013201","journal-title":"Am J Kidney Dis"},{"key":"4402_CR16","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1681\/ASN.2007050622","volume":"19","author":"GM London","year":"2008","unstructured":"London GM, Marchais SJ, Guerin AP, Boutouyrie P, M\u00e9tivier F, de Vernejoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 19:1827\u20131835","journal-title":"J Am Soc Nephrol"},{"key":"4402_CR17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"SK Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO4, Ca \u00d7 PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131\u20132138","journal-title":"J Am Soc Nephrol"},{"key":"4402_CR18","first-page":"S62","volume":"38","author":"HH Malluche","year":"1992","unstructured":"Malluche HH, Minier-Faugere MC (1992) Risk of adynamic bone disease in dialyzed patients. Kidney Int Suppl 38:S62\u2013S67","journal-title":"Kidney Int Suppl"},{"key":"4402_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5414\/CNP69269","volume":"69","author":"HH Malluche","year":"2008","unstructured":"Malluche HH, Monier-Faugere MC, Wang G, Fraz\u00e3 OJM, Charytan C, Coburn JW, Coyne DW, Kaplan MR, Baker N, McCary LC, Turner SA, Goodman WG (2008) An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol 69:269\u2013278","journal-title":"Clin Nephrol"},{"key":"4402_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ki.1993.64","volume":"43","author":"DJ Sherrard","year":"1993","unstructured":"Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure\u2014an evolving disorder. Kidney Int 43:436\u2013442","journal-title":"Kidney Int"},{"key":"4402_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/jbmr.1567","volume":"27","author":"H Qing","year":"2012","unstructured":"Qing H, Ardeshirpour L, Pajevic PD, Dusevich V, J\u00e4hn K, Kato S, Wysolmerski J, Bonewald LF (2012) Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation. J Bone Miner Res 27:1018\u20131029","journal-title":"J Bone Miner Res"},{"key":"4402_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2016.09.003","volume":"46","author":"LF Bonewald","year":"2017","unstructured":"Bonewald LF (2017) The role of the osteocyte in bone and nonbone disease. Endocrinol Metab Clin N Am 46:1\u201318 Review","journal-title":"Endocrinol Metab Clin N Am"},{"key":"4402_CR23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(02)08706-8","volume":"359","author":"E Seeman","year":"2002","unstructured":"Seeman E (2002) Pathogenesis and bone fragility in women and men. Lancet 359:1841\u20131850 Review","journal-title":"Lancet"},{"key":"4402_CR24","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","volume":"13","author":"AM Parfitt","year":"1998","unstructured":"Parfitt AM (1998) A structural approach to renal bone disease. J Bone Miner Res 13:1213\u20131220 Review","journal-title":"J Bone Miner Res"},{"key":"4402_CR25","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1210\/endo.133.6.8243296","volume":"133","author":"T Navey-Many","year":"1993","unstructured":"Navey-Many T, Silver J (1993) Effects of calcitriol, 22-oxacalcitriol, and calcipotriol on serum calcium and parathyroid hormone gene expression. Endocrinology 133:2724\u20132728","journal-title":"Endocrinology"},{"key":"4402_CR26","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1210\/endo.133.3.8396012","volume":"133","author":"AJ Brown","year":"1993","unstructured":"Brown AJ, Finch J, Grieff M, Ritter CS, Kubodera N, Nishii Y, Slatopolsky E (1993) The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine. Endocrinology 133:1158\u20131164","journal-title":"Endocrinology"},{"key":"4402_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/1744-9987.12242","volume":"19","author":"T Akizawa","year":"2015","unstructured":"Akizawa T, Akiba T, Hirakata H, Kinugasa E, Tominaga Y, Fukagawa M, Yokoyama K, Zhang W, Linde PG, Suzuki M (2015) Comparison of paricalcitol with maxacalcitol injection in Japanese hemodialysis patients with secondary hyperparathyroidism. Ther Apher Dial 19:225\u2013234","journal-title":"Ther Apher Dial"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4402-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4402-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:15:50Z","timestamp":1660522550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4402-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4402"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4402-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"28 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was conducted in accordance with the principles laid dawn in the Declaration of Helsinki. An explanation about both the risks and the outcomes of the bone biopsies and of the treatment was provided to the patient. And informed consent was obtained from the patient. The Institutional Review Board of Towa Hospital approved the consent form.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}